Swixx BioPharma Consolidates QMS, RIM, and Safety Processes Digital with the CARA Life Sciences Platform
Jan 11, 2024
LONDON - Jan. 11, 2024 - PRLog -- Generis, creator of the cloud data, content, and business process management platform CARA™, announces that Swixx BioPharma has selected the CARA Life Sciences Platform to digitise its QMS, RIM, and Safety processes.
Swixx BioPharma is a one of the largest and fastest-growing dedicated agents for biopharma in the Central, Eastern and South-Eastern regions of Europe and beyond. The organisation will adopt the CARA Life Sciences Platform to transform its processes to digital modes of working, increasing efficiency and thus supporting its exponential growth across the board.
"Finding a vendor with significant experience developing QMS and RIM solutions for clients in the pharmaceutical business was essential for us. We valued Generis' adaptability and desire to collaborate with us to create a solution that will satisfy our requirements on a long run. Because of their flexible solutions, comprehensive approach to master data management, and scalability to incorporate additional GxP-related activities and beyond, Generis became our preferred choice," said Katrin Jones, Regulatory and PV Quality System Director at Swixx.
"Swixx has experienced fast growth in all areas of the business; therefore, to support the expansion of the company, we strive to formalise and standardise our GxP processes with a modern, scalable platform. This will allow us to continue providing first-class services to partners, and proactively prepare for future challenges," said Dr Laur Saar, Medical, Regulatory and Pharmacovigilance Director at Swixx. Swixx will begin by implementing the CARA Life Sciences Platform for QMS and RIM, with plans to expand its usage to include Patient Safety solutions.
The CARA Life Sciences Platform provides a solid foundation based on industry standards and regulatory guidelines on which companies can easily configure specialist business processes. In addition, Master Data Management (MDM) offered on the CARA Life Sciences Platform sits on a single information lake, therefore all Regulatory, Quality, and other data is stored in a single repository, streamlining accessibility, traceability, and reuse of that data in other processes across the enterprise.
"The information lake approach offers substantial benefits and has a lot of potential for us. For instance, CARA offers a single interface for all departments and processes so there is no need for additional integrations, and being able to easily reuse our data is an advantage when expanding the Platform use and bringing in other processes," Katrin commented.
"We are delighted to be working with Swixx Biopharma. It underlines for us that the benefits of a scalable platform and consolidating multiple use cases into one system is as beneficial for large multinational pharma companies as for their partners, and we look forward to supporting Swixx in their journey with CARA and ensuring they get the maximum benefit from it," commented James Kelleher, CEO of Generis.
About Generis
Generis is a UK-headquartered developer of world-class data, content and business process management for regulated industries globally. 60% of the top 20 life sciences companies rely on Generis' flagship CARA™ Life Sciences Platform, including AbbVie, UCB, Biogen, Reckitt, Bristol Myers Squibb, Bayer, Pfizer, and Merck KGaA. Today Generis serves more than 750,000 users worldwide, across use cases ranging from RIM, Regulatory / R&D and Safety use cases to Clinical, Non-clinical, Quality GxP, CMC, Pharmacovigilance, Medical Information / Medical Affairs applications and more. More at generiscorp.com
About Swixx BioPharma AG
Swixx operates fully owned subsidiaries across Central and Eastern Europe, Greece, Russia and several Eurasian countries including Belarus, Kazakhstan, Moldova and Uzbekistan and now the Middle East. With over 1,200 employees and sales set to exceed 900M Euros in 2023, Swixx has swiftly evolved into the largest and fastest-growing dedicated agent for biopharma in the Central, Eastern and Southeastern regions of Europe and beyond. The company has gathered outstanding rare disease, oncology-hematology, specialty, vaccines and self-medication talent under one roof. For more information about Swixx, please visit: www.swixxbiopharma.com
Photos: (Click photo to enlarge)
Source: Generis
Read Full Story - Swixx BioPharma Consolidates QMS, RIM, and Safety Processes Digital with the CARA Life Sciences Platform | More news from this source
Press release distribution by PRLog
More News
Pastor claims the Rapture is just hours away as he announces new date for Jesus's return
A controversial pastor claims the end of the world has arrived, and millions of Christians will soon disappear as evil descends on Earth.
Storm Rachel batters Southern California, brings flooding to Las Vegas
Large waves from the post-tropical cyclone battered homes in Long Beach, and brought flooding to parts of Las Vegas near the famed Strip.
Could YOU survive the apocalypse? Experts reveal the skills you'll need when the world falls apart - and it's bad news for stockpilers
An expert has revealed the skills you need to survive an apocalyptic scenario, but they might not be what you expect.
Why Ketamine Immobilizes Some Users
Potent powders can produce a nearly catatonic state, particularly in those who have not tried the drug before.
Why Gen Z NEVER answers the phone: Young people say surprise calls trigger anxiety and feel like a demand for 'immediate attention'
For many young people, few things are more alarming than seeing their phone light up with an unexpected call.
⚡ Weekly Recap: Helpdesk 0-Days, Rogue Certs, ShinyHunters Arrest, AI-Fooling Malware and More
Some meetings last longer than it took attackers to jump on a newly disclosed security flaw this week. Within hours, they were already testing it. That's not much time to read the warning, let alone do something about it. But speed is only part of the problem. A secure connection didn't always mean a safe destination. People offering to fix a ransomware mess had questions to answer themselves.
AI minister warns 'likely' UK's cyber defences will be breached
Kanishka Narayan said the government will use advanced AI to strengthen the UK against cyber attacks.
Rapid spread of invasive lizards on Vancouver Island could have 'serious' environmental impact: experts
Biologist Nicholas Wong, science and operations manager with the Invasive Species Council of B.C., said there aren't any official management programs to oversee the population growth.
Millions face 'winter storm battleground' as new models predict heavy snow blasts in 19 US states
New forecast models for winter warn that millions of Americans may end up stuck in an arctic 'battleground' of snow and ice in just months.
OneReg enters UK market with Bristol Airport partnership
OneReg, the fast‑growing aviation compliance platform transforming how airports and airlines manage safety and certification, today announced its first UK partnership – with Bristol Airport, one of the country’s most ambitious and rapidly developing regional airports. The agreement will see OneReg’s digital compliance technology deployed across Bristol Airport’s operations, supporting the airport as it undertakes a major programme of investment in infrastructure, technology, and passenger experience. The partnership marks OneReg’s official entry into the UK market, following rapid expansion across Australasia, APAC and the Middle East.
2026 Paris Motor Show: Western carmakers face steep competition from Chinese rivals
The Paris Motor Show roars into gear this Monday, with over 200 auto sector brands showcasing their latest models and innovations. Chinese brands like BYD, Xpeng and Zeekr are among those present and getting lots of attention as their market share has surged in the past few years. In this edition, we speak to John Bozzella, CEO of the Alliance for Automotive Innovation, about the challenge these new competitors represent for the European and North American auto sectors.
Do you need to walk 10,000 steps a day?
Conventional wisdom sets 10,000 steps per day as a good target. That source of that number, though, is as questionable as Hippocrates’ quotation.
Recommended
Meta Unveils New Series of Advanced A.I. Models
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.